piracetam has been researched along with Recrudescence in 21 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Duodenal ulcer cure, as a systemic gastroenterologic disease, can be achieved in some patients by the addition of the nootropic drug piracetam to current antisecretory and antihelicobacter therapy." | 9.10 | [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer]. ( Shchetkin, DI; Tsimmerman, IaS, 2002) |
| "Objective The objective of this study was to compare clinical outcomes in children undergoing hematopoietic cell transplantation who received levetiracetam versus those who received phenytoin for the prevention of busulfan-induced seizures." | 7.85 | Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients. ( Floeter, AE; McCune, JS, 2017) |
| "This study aimed to evaluate the effectiveness of levetiracetam (LEV) use for seizure control in patients who had undergone resective surgery for intractable epilepsy in routine clinical practice." | 7.80 | Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study. ( An, DM; Chen, L; Lei, D; Li, JM; Li, YH; Zeng, TF; Zhang, B; Zhou, D, 2014) |
| "A retrospective study to evaluate the efficacy of levetiracetam in the treatment of adult pharmacoresistant epilepsy." | 7.74 | [Clinical experience with levetiracetam for adults with epilepsy]. ( Barcs, G; Szucs, A, 2007) |
| "Piracetam was significantly superior to ASA in the secondary endpoint (P=0." | 6.69 | Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study. ( Evers, S; Fischer, M; Grotemeyer, KH; Husstedt, IW, 2000) |
| "Benzodiazepines are used as first-line treatments for status epilepticus." | 5.46 | Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. ( Daidoji, H; Doi, K; Hashimoto, H; Hiruma, T; Inokuchi, R; Morimura, N; Nakamura, K; Naraba, H; Sonoo, T; Tokunaga, K, 2017) |
| "Duodenal ulcer cure, as a systemic gastroenterologic disease, can be achieved in some patients by the addition of the nootropic drug piracetam to current antisecretory and antihelicobacter therapy." | 5.10 | [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer]. ( Shchetkin, DI; Tsimmerman, IaS, 2002) |
| "Objective The objective of this study was to compare clinical outcomes in children undergoing hematopoietic cell transplantation who received levetiracetam versus those who received phenytoin for the prevention of busulfan-induced seizures." | 3.85 | Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients. ( Floeter, AE; McCune, JS, 2017) |
| "This study aimed to evaluate the effectiveness of levetiracetam (LEV) use for seizure control in patients who had undergone resective surgery for intractable epilepsy in routine clinical practice." | 3.80 | Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study. ( An, DM; Chen, L; Lei, D; Li, JM; Li, YH; Zeng, TF; Zhang, B; Zhou, D, 2014) |
| "A retrospective study to evaluate the efficacy of levetiracetam in the treatment of adult pharmacoresistant epilepsy." | 3.74 | [Clinical experience with levetiracetam for adults with epilepsy]. ( Barcs, G; Szucs, A, 2007) |
| "Piracetam was significantly superior to ASA in the secondary endpoint (P=0." | 2.69 | Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study. ( Evers, S; Fischer, M; Grotemeyer, KH; Husstedt, IW, 2000) |
| "Although antiepileptic drugs (AEDs) are commonly used to control and prevent seizures, their long-term use carries a considerable risk of morbidity." | 2.41 | Antiepileptic drug therapy for adults: when to initiate and how to choose. ( Sirven, JI, 2002) |
| " At the onset of fever, the patients who presented epileptiform discharge were orally administered with LEV with a dose of 15-30 mg/kg per day twice daily for 1 week, thereafter, the dosage was gradually reduced until totally discontinued in the second week." | 1.48 | Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study. ( Hu, LY; Li, H; Ma, SF; Shi, XY; Zhang, MN; Zou, LP, 2018) |
| "Benzodiazepines are used as first-line treatments for status epilepticus." | 1.46 | Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. ( Daidoji, H; Doi, K; Hashimoto, H; Hiruma, T; Inokuchi, R; Morimura, N; Nakamura, K; Naraba, H; Sonoo, T; Tokunaga, K, 2017) |
| "Complete seizure freedom was defined as a favorable outcome." | 1.38 | Levetiracetam may favorably affect seizure outcome after temporal lobectomy. ( Bingaman, W; Irwin, AI; Jehi, LE; Kayyali, H; Najm, I; Vadera, S, 2012) |
| "The findings of this study provide some evidence that levetiracetam is an efficacious and safe treatment option for outpatient alcohol detoxification." | 1.36 | Efficacy and safety of levetiracetam for outpatient alcohol detoxification. ( Förg, A; Heimann, HM; Hein, J; Heinz, A; Hinzpeter, A; Müller, CA; Schäfer, M; Schneider, S; Volkmar, K, 2010) |
| "Five days later, febrile convulsions were induced by hyperthermal bath (45 Celcius degree)." | 1.36 | [Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats]. ( Cheng, M; Huang, Z; Li, SX, 2010) |
| "He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam." | 1.33 | Suppression of myoclonus in SCA2 by piracetam. ( Barbieri, F; de Falco, A; De Michele, G; De Rosa, A; Filla, A; Rinaldi, C; Striano, P; Striano, S; Tucci, T, 2006) |
| "Migraine (63." | 1.32 | Efficacy and safety of levetiracetam in pediatric migraine. ( Miller, GS, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K | 1 |
| Inokuchi, R | 1 |
| Daidoji, H | 1 |
| Naraba, H | 1 |
| Sonoo, T | 1 |
| Hashimoto, H | 1 |
| Tokunaga, K | 1 |
| Hiruma, T | 1 |
| Doi, K | 1 |
| Morimura, N | 1 |
| Hu, LY | 1 |
| Shi, XY | 1 |
| Li, H | 1 |
| Zhang, MN | 1 |
| Ma, SF | 1 |
| Zou, LP | 1 |
| Finsterer, J | 1 |
| Höftberger, R | 1 |
| Rolinski, B | 1 |
| Stöllberger, C | 1 |
| Wöhrer, A | 1 |
| Winkler, WB | 1 |
| Meyer, S | 1 |
| Oster, I | 1 |
| Peterlini, S | 1 |
| Gortner, L | 1 |
| Kutschke, G | 1 |
| Zeng, TF | 1 |
| Li, YH | 1 |
| An, DM | 1 |
| Chen, L | 1 |
| Lei, D | 1 |
| Zhang, B | 1 |
| Li, JM | 1 |
| Zhou, D | 1 |
| Floeter, AE | 1 |
| McCune, JS | 1 |
| Marchione, P | 1 |
| Vento, C | 1 |
| Marianetti, M | 1 |
| Romeo, T | 1 |
| Amabile, GA | 1 |
| Giacomini, P | 1 |
| Müller, CA | 1 |
| Schäfer, M | 1 |
| Schneider, S | 1 |
| Heimann, HM | 1 |
| Hinzpeter, A | 1 |
| Volkmar, K | 1 |
| Förg, A | 1 |
| Heinz, A | 1 |
| Hein, J | 1 |
| Cheng, M | 1 |
| Huang, Z | 1 |
| Li, SX | 1 |
| Lukkarinen, H | 1 |
| Virtanen, I | 1 |
| Arikka, H | 1 |
| Arola, A | 1 |
| Peltola, M | 1 |
| Ekblad, H | 1 |
| Drust, A | 1 |
| Luchtmann, M | 1 |
| Firsching, R | 1 |
| Tröger, U | 1 |
| Martens-Lobenhoffer, J | 1 |
| Bode-Böger, SM | 1 |
| Jehi, LE | 1 |
| Irwin, AI | 1 |
| Kayyali, H | 1 |
| Vadera, S | 1 |
| Bingaman, W | 1 |
| Najm, I | 1 |
| Sirven, JI | 1 |
| Pinto, A | 1 |
| Sander, JW | 1 |
| Miller, GS | 1 |
| Moriau, M | 1 |
| Lavenne-Pardonge, E | 1 |
| Crasborn, L | 1 |
| von Frenckell, R | 1 |
| Col-Debeys, C | 1 |
| Richards, KC | 1 |
| Smith, MC | 1 |
| Verma, A | 1 |
| De Rosa, A | 1 |
| Striano, P | 1 |
| Barbieri, F | 1 |
| de Falco, A | 1 |
| Rinaldi, C | 1 |
| Tucci, T | 1 |
| Striano, S | 1 |
| Filla, A | 1 |
| De Michele, G | 1 |
| Barcs, G | 1 |
| Szucs, A | 1 |
| Grotemeyer, KH | 1 |
| Evers, S | 1 |
| Fischer, M | 1 |
| Husstedt, IW | 1 |
| Tsimmerman, IaS | 1 |
| Shchetkin, DI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China[NCT02550028] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2015-09-01 | Terminated (stopped due to The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for piracetam and Recrudescence
| Article | Year |
|---|---|
Antiepileptic drug therapy for adults: when to initiate and how to choose.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Felb | 2002 |
Levetiracetam: a new therapeutic option for refractory epilepsy.
Topics: Animals; Anticonvulsants; Chronic Disease; Drug Evaluation; Drug Interactions; Epilepsy; Humans; Lev | 2003 |
3 trials available for piracetam and Recrudescence
| Article | Year |
|---|---|
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants.
Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Blood Viscosity; Dipyridamole; Drug Ther | 1995 |
Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study.
Topics: Aspirin; Blood Platelets; Demography; Double-Blind Method; Endpoint Determination; Female; Follow-Up | 2000 |
[Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer].
Topics: Adolescent; Adult; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulc | 2002 |
16 other studies available for piracetam and Recrudescence
| Article | Year |
|---|---|
Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
Topics: Administration, Intravenous; Administration, Oral; Anticonvulsants; Blood Pressure; Databases, Factu | 2017 |
Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study.
Topics: Administration, Oral; Ambulatory Care; Anticonvulsants; Child, Preschool; Cohort Studies; Comorbidit | 2018 |
Presumed mitochondrial disease manifesting with recurrent syncopes.
Topics: Aged; Anticonvulsants; Autonomic Nervous System Diseases; Biopsy; Catheter Ablation; Electrocardiogr | 2014 |
Recurrent severe ulcers due to seizures.
Topics: Anticonvulsants; Electroencephalography; Female; Humans; Infant; Levetiracetam; Mouth Protectors; Or | 2014 |
Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Child; Epilepsy; Female; Follow-Up Studies; Humans; | 2014 |
Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
Topics: Adolescent; Anticonvulsants; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoiet | 2017 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res | 2009 |
Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Alcoholism; Ambulatory Care; Anticonvulsants; Female; Hum | 2010 |
[Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats].
Topics: Animals; Anticonvulsants; Levetiracetam; Male; Phenobarbital; Piracetam; Rats; Recurrence; Seizures, | 2010 |
Recurrent sinus arrest and asystole due to breath-holding spell in a toddler; recovery with levetiracetam-therapy.
Topics: Anticonvulsants; Electrocardiography; European Union; Female; Heart Arrest; Humans; Infant; Levetira | 2010 |
Recurrent seizures in a levetiracetam-treated patient after subarachnoid hemorrhage: a matter of enhanced renal function?
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Recurrence; Seizures; Subara | 2012 |
Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
Topics: Adolescent; Adult; Aged; Anterior Temporal Lobectomy; Anticonvulsants; Child; Child, Preschool; Epil | 2012 |
Efficacy and safety of levetiracetam in pediatric migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Levetiracetam; Male; Migraine | 2004 |
Continued use of zonisamide following development of renal calculi.
Topics: Adult; Anticonvulsants; Calcium Citrate; Carbamazepine; Drug Therapy, Combination; Fluid Therapy; Hu | 2005 |
Suppression of myoclonus in SCA2 by piracetam.
Topics: Adult; Ataxia; Ataxins; Dose-Response Relationship, Drug; Gait Ataxia; Humans; Infusions, Intravenou | 2006 |
[Clinical experience with levetiracetam for adults with epilepsy].
Topics: Adult; Aged; Anticonvulsants; Drug Resistance; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2007 |